SV2002000189A - SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG - Google Patents

SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG

Info

Publication number
SV2002000189A
SV2002000189A SV2000000189A SV2000000189A SV2002000189A SV 2002000189 A SV2002000189 A SV 2002000189A SV 2000000189 A SV2000000189 A SV 2000000189A SV 2000000189 A SV2000000189 A SV 2000000189A SV 2002000189 A SV2002000189 A SV 2002000189A
Authority
SV
El Salvador
Prior art keywords
receiver antagonist
antagonist
receiver
structural analog
synthetic combinations
Prior art date
Application number
SV2000000189A
Other languages
Spanish (es)
Inventor
John Hughes
Lakhbir Singh
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV2002000189A publication Critical patent/SV2002000189A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA METODOS DE TRATAMIENTO USANDO COMBINACIONES SINERGISTICAS DE UN ANTAGONISTA DE RECEPTOR DE NK1 Y EL ANALOGO DE GABA, Y COMPOSICIONES FARMACEUTICAS Y PRODUCTOS QUE CONTIENEN EL ANTAGONISTA DE RECEPTOR DE NK1Y EL ANALOGO DE GABA.LA PRESENTE INVENCION TAMBIEN PROPORCIONA EL USO DE UN ANTAGONISTA DE RECEPTOR DE NK1 Y UN ANALOGO DE GABA PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O LA PREVENCION DEL DOLOR CRONICO.THE PRESENT INVENTION PROVIDES METHODS OF TREATMENT USING SYNERGISTIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND GABA ANALOG, AND PHARMACEUTICAL COMPOSITIONS AND PRODUCTS CONTAINING THE NK1 RECEIVER ANTAGONIST AND THE MANUFACTURING ANALOGUE PRESENTATION. NK1 RECEIVER ANTAGONIST AND A GABA ANALOG FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF CHRONIC PAIN.

SV2000000189A 1999-10-07 2000-10-06 SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG SV2002000189A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5827199A 1999-10-07 1999-10-07

Publications (1)

Publication Number Publication Date
SV2002000189A true SV2002000189A (en) 2002-12-13

Family

ID=40091693

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2000000189A SV2002000189A (en) 1999-10-07 2000-10-06 SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG

Country Status (1)

Country Link
SV (1) SV2002000189A (en)

Similar Documents

Publication Publication Date Title
CY1120313T1 (en) MEDICINAL COMPOSITION FOR LEATHER USE TO TREAT PREVENTION WHICH INCLUDES Vitamin D And Corticosteroids
CY1115484T1 (en) UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND CONCLUSIONS, AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES AND DISEASE
AR032132A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF A TRAMADOL COMPOUND AND ANTI-CONVULSIVE DRUG AND USE OF THE COMBINATION TO PREPARE A MEDICINAL PRODUCT
CY1107894T1 (en) GABA analogue prodrugs, their compositions and uses
NO20022058D0 (en) Pharmaceutical compositions
ES2156028T3 (en) Compositions containing tetrahydrolipstatin
PA8504301A1 (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
ES2193337T3 (en) USE OF STRONTIUM SALTS FOR THE TREATMENT OF ARTROSIS.
DK0954314T3 (en) Dosage forms for ameliorating male erectile dysfunction
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
SV2002000189A (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG
ES2194129T3 (en) PHARMACEUTICAL COMPOUNDS.
BR0204889A (en) Pain Reduction Kit
AR059965A2 (en) USE OF 8,9-DEHYDROESTRONE FOR THE PREPARATION OF AN ANTIOXIDANT MEDICINAL PRODUCT
ECSP003696A (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG
DOP2000000076A (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG. (SYNERGISTIC COMBINATIONS OF A NKI RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG)
BR0109477A (en) Use of cdp-choline for the treatment of alcohol suppression syndrome
BR0104005A (en) Pharmaceutical composition for the prevention or treatment of a disease associated with an overproduction of il-2
BR0311209A (en) Method of producing pharmaceutical dosage units for oral administration, use of etonogestrel, and tablet
PT942729E (en) UTILIZATION OF NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF STRESSE DISEASES
BR0311141A (en) Synergistically interaction of abacavir and alovudine
AR018328A1 (en) CRYSTAL FORM OF THE 1S- [1 ALPHA (2S *, 3R *), 9 ALPHA -] - 6,10-DIOXO-N- (2-ETOXI-5-OXO-TETRAHIDRO-3-FURANIL) -9 - [[ (1-ISOQUINOLIL) CARBONIL] AMINO] OCTAHIDRO-6-H-PIRIDAZINO [1,2-A] [1,2] DIAZEPINA-1-CARBOXAMIDE, ITS PREPARATION PROCEDURE, ITS APPLICATION IN THE PREPARATION OF A MEDICINAL PRODUCT, AND COMPOSITION
CY1114949T1 (en) UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND CONCLUSIONS, AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES AND DISEASE